Wearable Atrial Fibrillation Detection Devices Market Size is expected to record a commendable CAGR between the years 2022 and 2028. This growth is on account of increasing emphasis on the timely diagnosis and treatment of atrial fibrillation given that it is a prominent cause of mortality and morbidity at the global level. Numerous manufacturers are, therefore, focusing on harnessing the potential of existing and emerging mobile technologies for the identification of AF in a variety of community and clinical settings.
On the basis of components, the hardware segment is estimated to account for a substantial share in the wearable atrial fibrillation detection devices market through 2028. This rise can be attributed to the availability of a range of wearable devices in healthcare. Some of these devices include smart patches, rings, watches and others. Of these, ring-type wearables, equipped with deep learning analysis of PPG signals could help in the accurate diagnosis of AF without depending on electrocardiography. Similar devices enable the continuous monitoring of AF in high-risk populations.
By application, the smart watches segment is projected to register appreciable growth by 2028 owing to the extensive adoption of these devices and their demonstrated accuracy in screening individuals for AF. Furthermore, the use of PPG in smartwatches helps patients in taking an ECG with the tap of a button. The devices can be considered as screening tools for people at high risk of the condition because of increased age or factors pertaining to cardiovascular risk.
Citing the regional landscape, North America wearable atrial fibrillation detection devices market share is anticipated to depict lucrative growth up to 2028. This upsurge is due to an increase in clearances by regulators in the region. For instance, in October 2021, Withings secured the approval of the FDA for its ScanWatch. The device is capable of measuring blood oxygen levels from the wrist and can help in the detection of AF via a medical-grade ECG.
Major players across the wearable atrial fibrillation detection devices market comprise Apple, Inc., AliveCor, Cardiac Insight, Applied Cardiac Systems, LifeWatch (BioTelemetry), Garmin, and CardioNet.
These companies are taking a keen interest in the implementation of strategic initiatives such as mergers, acquisitions, partnerships, collaborations, and others for the consolidation of their position in the wearable atrial fibrillation detection devices market.
Some of the instances have been mentioned below:
The SARS-CoV-2 pandemic led to the prevention of a number of patients from availing in-person services. This advocated the requirement for remote patient monitoring solutions and wearable devices for minimizing interruptions in healthcare. While the number of people themselves deploying these devices was far low before the coronavirus crisis, the pandemic led to a dramatic rise in these figures. This has created the need for the development and rollout of technologically advanced wearable cardiac monitoring devices and solutions on the market.
Market, By Component
Market, By Application
Market, By Age
Market, By Distribution Channel
Market, By Technology
The above information is provided for the following regions and countries: